Fig. 1: Schematic illustration of MW-TMPs as an effective immunotherapy and drug delivery platform for LUAD treatment. | Nature Nanotechnology

Fig. 1: Schematic illustration of MW-TMPs as an effective immunotherapy and drug delivery platform for LUAD treatment.

From: Tumour-derived microparticles obtained through microwave irradiation induce immunogenic cell death in lung adenocarcinoma

Fig. 1

a, MW-TMPs, derived from MW-stimulated dying LLC cells, are enriched with HMGB1 and can effectively deliver small-molecule drugs, such as MTX. b, MW-TMPs induce ICD and prime the subsequent chain reaction of antitumour immunity in the TME. c, MW-TMPs enable dual targeting of tumour cells by NK and T cells and reprogramme TAMs into antitumour subtypes. d, Multiple preclinical tumour models. TCR, T cell receptor.

Back to article page